Patents by Inventor Andrew Wallace Boyd

Andrew Wallace Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Receptor-ligand system and assay
    Patent number: 7037662
    Abstract: An Eph family RTK (receptor tyrosine kinase) ligand-binding domain as well as a method of identifying Eph family RTK agonists or antagonist. The ligand-binding domain is suitably encoded by exon III of a gone encoding the RTK of the Eph family and may additionally include an amino acid sequence encoded by exon II of the gene. The ligand-binding domain may be a polypeptide having amino acids 57-271 of the sequence shown in FIG. 1.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: May 2, 2006
    Inventors: Andrew Wallace Boyd, Mirella Dottori, Martin Lackmann
  • Monoclonal antibody to human granulocyte macrophage colony stimulating factor
    Patent number: 5747032
    Abstract: The invention relates to monoclonal antibodies specific for the receptor for human granulocyte-macrophage colony stimulating factor (hGM-CSF). The antibodies inhibit the biological activity of hGM-CSF. Methods and compositions for treatment of GM-CSF dependent condition, and methods for screening of selective antagonists to GM-CSF, are also disclosed and claimed.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: May 5, 1998
    Assignee: Amrad Corporation Limited
    Inventors: Donald Metcalf, Nicos Antony Nicola, Andrew Wallace Boyd, Judith Eleanor Layton, Kaye Wycherley